Global Lung Cancer Biomarkers Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Lung Cancer Biomarkers market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Lung Cancer Biomarkers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Lung Cancer Biomarkers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Lung Cancer Biomarkers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Lung Cancer Biomarkers players cover Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Lung Cancer Biomarkers Industry Forecast” looks at past sales and reviews total world Lung Cancer Biomarkers sales in 2024, providing a comprehensive analysis by region and market sector of projected Lung Cancer Biomarkers sales for 2025 through 2031. With Lung Cancer Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Cancer Biomarkers industry.
This Insight Report provides a comprehensive analysis of the global Lung Cancer Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lung Cancer Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lung Cancer Biomarkers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Cancer Biomarkers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Cancer Biomarkers.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung Cancer Biomarkers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Lung Cancer Biomarkers market?
What factors are driving Lung Cancer Biomarkers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lung Cancer Biomarkers market opportunities vary by end market size?
How does Lung Cancer Biomarkers break out by Type, by Application?
The global Lung Cancer Biomarkers market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Lung Cancer Biomarkers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Lung Cancer Biomarkers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Lung Cancer Biomarkers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Lung Cancer Biomarkers players cover Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Lung Cancer Biomarkers Industry Forecast” looks at past sales and reviews total world Lung Cancer Biomarkers sales in 2024, providing a comprehensive analysis by region and market sector of projected Lung Cancer Biomarkers sales for 2025 through 2031. With Lung Cancer Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Cancer Biomarkers industry.
This Insight Report provides a comprehensive analysis of the global Lung Cancer Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lung Cancer Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lung Cancer Biomarkers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Cancer Biomarkers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Cancer Biomarkers.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung Cancer Biomarkers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Protein Biomarker
- Genetic Biomarker
- Diagnostics
- Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bio-Rad Laboratories
- Roche Diagnostics
- Qiagen
- Illumina
- GE Healthcare
- Agilent Technologies
- Biomerieux SA
- Merck
- Abbott Laboratories
- Becton, Dickinson and Company
- Danaher Corporation
- Myriad Genetics
- Sysmex Corporation
- Hologic
What is the 10-year outlook for the global Lung Cancer Biomarkers market?
What factors are driving Lung Cancer Biomarkers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lung Cancer Biomarkers market opportunities vary by end market size?
How does Lung Cancer Biomarkers break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Cancer Biomarkers Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lung Cancer Biomarkers by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lung Cancer Biomarkers by Country/Region, 2020, 2024 & 2031
2.2 Lung Cancer Biomarkers Segment by Type
2.2.1 Protein Biomarker
2.2.2 Genetic Biomarker
2.3 Lung Cancer Biomarkers Sales by Type
2.3.1 Global Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
2.3.2 Global Lung Cancer Biomarkers Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lung Cancer Biomarkers Sale Price by Type (2020-2025)
2.4 Lung Cancer Biomarkers Segment by Application
2.4.1 Diagnostics
2.4.2 Research
2.4.3 Others
2.5 Lung Cancer Biomarkers Sales by Application
2.5.1 Global Lung Cancer Biomarkers Sale Market Share by Application (2020-2025)
2.5.2 Global Lung Cancer Biomarkers Revenue and Market Share by Application (2020-2025)
2.5.3 Global Lung Cancer Biomarkers Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Lung Cancer Biomarkers Breakdown Data by Company
3.1.1 Global Lung Cancer Biomarkers Annual Sales by Company (2020-2025)
3.1.2 Global Lung Cancer Biomarkers Sales Market Share by Company (2020-2025)
3.2 Global Lung Cancer Biomarkers Annual Revenue by Company (2020-2025)
3.2.1 Global Lung Cancer Biomarkers Revenue by Company (2020-2025)
3.2.2 Global Lung Cancer Biomarkers Revenue Market Share by Company (2020-2025)
3.3 Global Lung Cancer Biomarkers Sale Price by Company
3.4 Key Manufacturers Lung Cancer Biomarkers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lung Cancer Biomarkers Product Location Distribution
3.4.2 Players Lung Cancer Biomarkers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LUNG CANCER BIOMARKERS BY GEOGRAPHIC REGION
4.1 World Historic Lung Cancer Biomarkers Market Size by Geographic Region (2020-2025)
4.1.1 Global Lung Cancer Biomarkers Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lung Cancer Biomarkers Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lung Cancer Biomarkers Market Size by Country/Region (2020-2025)
4.2.1 Global Lung Cancer Biomarkers Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lung Cancer Biomarkers Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lung Cancer Biomarkers Sales Growth
4.4 APAC Lung Cancer Biomarkers Sales Growth
4.5 Europe Lung Cancer Biomarkers Sales Growth
4.6 Middle East & Africa Lung Cancer Biomarkers Sales Growth
5 AMERICAS
5.1 Americas Lung Cancer Biomarkers Sales by Country
5.1.1 Americas Lung Cancer Biomarkers Sales by Country (2020-2025)
5.1.2 Americas Lung Cancer Biomarkers Revenue by Country (2020-2025)
5.2 Americas Lung Cancer Biomarkers Sales by Type (2020-2025)
5.3 Americas Lung Cancer Biomarkers Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Biomarkers Sales by Region
6.1.1 APAC Lung Cancer Biomarkers Sales by Region (2020-2025)
6.1.2 APAC Lung Cancer Biomarkers Revenue by Region (2020-2025)
6.2 APAC Lung Cancer Biomarkers Sales by Type (2020-2025)
6.3 APAC Lung Cancer Biomarkers Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lung Cancer Biomarkers by Country
7.1.1 Europe Lung Cancer Biomarkers Sales by Country (2020-2025)
7.1.2 Europe Lung Cancer Biomarkers Revenue by Country (2020-2025)
7.2 Europe Lung Cancer Biomarkers Sales by Type (2020-2025)
7.3 Europe Lung Cancer Biomarkers Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Cancer Biomarkers by Country
8.1.1 Middle East & Africa Lung Cancer Biomarkers Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lung Cancer Biomarkers Revenue by Country (2020-2025)
8.2 Middle East & Africa Lung Cancer Biomarkers Sales by Type (2020-2025)
8.3 Middle East & Africa Lung Cancer Biomarkers Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lung Cancer Biomarkers
10.3 Manufacturing Process Analysis of Lung Cancer Biomarkers
10.4 Industry Chain Structure of Lung Cancer Biomarkers
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lung Cancer Biomarkers Distributors
11.3 Lung Cancer Biomarkers Customer
12 WORLD FORECAST REVIEW FOR LUNG CANCER BIOMARKERS BY GEOGRAPHIC REGION
12.1 Global Lung Cancer Biomarkers Market Size Forecast by Region
12.1.1 Global Lung Cancer Biomarkers Forecast by Region (2026-2031)
12.1.2 Global Lung Cancer Biomarkers Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lung Cancer Biomarkers Forecast by Type (2026-2031)
12.7 Global Lung Cancer Biomarkers Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bio-Rad Laboratories
13.1.1 Bio-Rad Laboratories Company Information
13.1.2 Bio-Rad Laboratories Lung Cancer Biomarkers Product Portfolios and Specifications
13.1.3 Bio-Rad Laboratories Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bio-Rad Laboratories Main Business Overview
13.1.5 Bio-Rad Laboratories Latest Developments
13.2 Roche Diagnostics
13.2.1 Roche Diagnostics Company Information
13.2.2 Roche Diagnostics Lung Cancer Biomarkers Product Portfolios and Specifications
13.2.3 Roche Diagnostics Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Diagnostics Main Business Overview
13.2.5 Roche Diagnostics Latest Developments
13.3 Qiagen
13.3.1 Qiagen Company Information
13.3.2 Qiagen Lung Cancer Biomarkers Product Portfolios and Specifications
13.3.3 Qiagen Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Qiagen Main Business Overview
13.3.5 Qiagen Latest Developments
13.4 Illumina
13.4.1 Illumina Company Information
13.4.2 Illumina Lung Cancer Biomarkers Product Portfolios and Specifications
13.4.3 Illumina Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Illumina Main Business Overview
13.4.5 Illumina Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Lung Cancer Biomarkers Product Portfolios and Specifications
13.5.3 GE Healthcare Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Agilent Technologies
13.6.1 Agilent Technologies Company Information
13.6.2 Agilent Technologies Lung Cancer Biomarkers Product Portfolios and Specifications
13.6.3 Agilent Technologies Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Agilent Technologies Main Business Overview
13.6.5 Agilent Technologies Latest Developments
13.7 Biomerieux SA
13.7.1 Biomerieux SA Company Information
13.7.2 Biomerieux SA Lung Cancer Biomarkers Product Portfolios and Specifications
13.7.3 Biomerieux SA Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Biomerieux SA Main Business Overview
13.7.5 Biomerieux SA Latest Developments
13.8 Merck
13.8.1 Merck Company Information
13.8.2 Merck Lung Cancer Biomarkers Product Portfolios and Specifications
13.8.3 Merck Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merck Main Business Overview
13.8.5 Merck Latest Developments
13.9 Abbott Laboratories
13.9.1 Abbott Laboratories Company Information
13.9.2 Abbott Laboratories Lung Cancer Biomarkers Product Portfolios and Specifications
13.9.3 Abbott Laboratories Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Abbott Laboratories Main Business Overview
13.9.5 Abbott Laboratories Latest Developments
13.10 Becton, Dickinson and Company
13.10.1 Becton, Dickinson and Company Company Information
13.10.2 Becton, Dickinson and Company Lung Cancer Biomarkers Product Portfolios and Specifications
13.10.3 Becton, Dickinson and Company Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Becton, Dickinson and Company Main Business Overview
13.10.5 Becton, Dickinson and Company Latest Developments
13.11 Danaher Corporation
13.11.1 Danaher Corporation Company Information
13.11.2 Danaher Corporation Lung Cancer Biomarkers Product Portfolios and Specifications
13.11.3 Danaher Corporation Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Danaher Corporation Main Business Overview
13.11.5 Danaher Corporation Latest Developments
13.12 Myriad Genetics
13.12.1 Myriad Genetics Company Information
13.12.2 Myriad Genetics Lung Cancer Biomarkers Product Portfolios and Specifications
13.12.3 Myriad Genetics Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Myriad Genetics Main Business Overview
13.12.5 Myriad Genetics Latest Developments
13.13 Sysmex Corporation
13.13.1 Sysmex Corporation Company Information
13.13.2 Sysmex Corporation Lung Cancer Biomarkers Product Portfolios and Specifications
13.13.3 Sysmex Corporation Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sysmex Corporation Main Business Overview
13.13.5 Sysmex Corporation Latest Developments
13.14 Hologic
13.14.1 Hologic Company Information
13.14.2 Hologic Lung Cancer Biomarkers Product Portfolios and Specifications
13.14.3 Hologic Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Hologic Main Business Overview
13.14.5 Hologic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Cancer Biomarkers Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lung Cancer Biomarkers by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lung Cancer Biomarkers by Country/Region, 2020, 2024 & 2031
2.2 Lung Cancer Biomarkers Segment by Type
2.2.1 Protein Biomarker
2.2.2 Genetic Biomarker
2.3 Lung Cancer Biomarkers Sales by Type
2.3.1 Global Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
2.3.2 Global Lung Cancer Biomarkers Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lung Cancer Biomarkers Sale Price by Type (2020-2025)
2.4 Lung Cancer Biomarkers Segment by Application
2.4.1 Diagnostics
2.4.2 Research
2.4.3 Others
2.5 Lung Cancer Biomarkers Sales by Application
2.5.1 Global Lung Cancer Biomarkers Sale Market Share by Application (2020-2025)
2.5.2 Global Lung Cancer Biomarkers Revenue and Market Share by Application (2020-2025)
2.5.3 Global Lung Cancer Biomarkers Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Lung Cancer Biomarkers Breakdown Data by Company
3.1.1 Global Lung Cancer Biomarkers Annual Sales by Company (2020-2025)
3.1.2 Global Lung Cancer Biomarkers Sales Market Share by Company (2020-2025)
3.2 Global Lung Cancer Biomarkers Annual Revenue by Company (2020-2025)
3.2.1 Global Lung Cancer Biomarkers Revenue by Company (2020-2025)
3.2.2 Global Lung Cancer Biomarkers Revenue Market Share by Company (2020-2025)
3.3 Global Lung Cancer Biomarkers Sale Price by Company
3.4 Key Manufacturers Lung Cancer Biomarkers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lung Cancer Biomarkers Product Location Distribution
3.4.2 Players Lung Cancer Biomarkers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LUNG CANCER BIOMARKERS BY GEOGRAPHIC REGION
4.1 World Historic Lung Cancer Biomarkers Market Size by Geographic Region (2020-2025)
4.1.1 Global Lung Cancer Biomarkers Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lung Cancer Biomarkers Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lung Cancer Biomarkers Market Size by Country/Region (2020-2025)
4.2.1 Global Lung Cancer Biomarkers Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lung Cancer Biomarkers Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lung Cancer Biomarkers Sales Growth
4.4 APAC Lung Cancer Biomarkers Sales Growth
4.5 Europe Lung Cancer Biomarkers Sales Growth
4.6 Middle East & Africa Lung Cancer Biomarkers Sales Growth
5 AMERICAS
5.1 Americas Lung Cancer Biomarkers Sales by Country
5.1.1 Americas Lung Cancer Biomarkers Sales by Country (2020-2025)
5.1.2 Americas Lung Cancer Biomarkers Revenue by Country (2020-2025)
5.2 Americas Lung Cancer Biomarkers Sales by Type (2020-2025)
5.3 Americas Lung Cancer Biomarkers Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Biomarkers Sales by Region
6.1.1 APAC Lung Cancer Biomarkers Sales by Region (2020-2025)
6.1.2 APAC Lung Cancer Biomarkers Revenue by Region (2020-2025)
6.2 APAC Lung Cancer Biomarkers Sales by Type (2020-2025)
6.3 APAC Lung Cancer Biomarkers Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lung Cancer Biomarkers by Country
7.1.1 Europe Lung Cancer Biomarkers Sales by Country (2020-2025)
7.1.2 Europe Lung Cancer Biomarkers Revenue by Country (2020-2025)
7.2 Europe Lung Cancer Biomarkers Sales by Type (2020-2025)
7.3 Europe Lung Cancer Biomarkers Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Cancer Biomarkers by Country
8.1.1 Middle East & Africa Lung Cancer Biomarkers Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lung Cancer Biomarkers Revenue by Country (2020-2025)
8.2 Middle East & Africa Lung Cancer Biomarkers Sales by Type (2020-2025)
8.3 Middle East & Africa Lung Cancer Biomarkers Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lung Cancer Biomarkers
10.3 Manufacturing Process Analysis of Lung Cancer Biomarkers
10.4 Industry Chain Structure of Lung Cancer Biomarkers
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lung Cancer Biomarkers Distributors
11.3 Lung Cancer Biomarkers Customer
12 WORLD FORECAST REVIEW FOR LUNG CANCER BIOMARKERS BY GEOGRAPHIC REGION
12.1 Global Lung Cancer Biomarkers Market Size Forecast by Region
12.1.1 Global Lung Cancer Biomarkers Forecast by Region (2026-2031)
12.1.2 Global Lung Cancer Biomarkers Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lung Cancer Biomarkers Forecast by Type (2026-2031)
12.7 Global Lung Cancer Biomarkers Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bio-Rad Laboratories
13.1.1 Bio-Rad Laboratories Company Information
13.1.2 Bio-Rad Laboratories Lung Cancer Biomarkers Product Portfolios and Specifications
13.1.3 Bio-Rad Laboratories Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bio-Rad Laboratories Main Business Overview
13.1.5 Bio-Rad Laboratories Latest Developments
13.2 Roche Diagnostics
13.2.1 Roche Diagnostics Company Information
13.2.2 Roche Diagnostics Lung Cancer Biomarkers Product Portfolios and Specifications
13.2.3 Roche Diagnostics Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Diagnostics Main Business Overview
13.2.5 Roche Diagnostics Latest Developments
13.3 Qiagen
13.3.1 Qiagen Company Information
13.3.2 Qiagen Lung Cancer Biomarkers Product Portfolios and Specifications
13.3.3 Qiagen Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Qiagen Main Business Overview
13.3.5 Qiagen Latest Developments
13.4 Illumina
13.4.1 Illumina Company Information
13.4.2 Illumina Lung Cancer Biomarkers Product Portfolios and Specifications
13.4.3 Illumina Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Illumina Main Business Overview
13.4.5 Illumina Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Lung Cancer Biomarkers Product Portfolios and Specifications
13.5.3 GE Healthcare Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Agilent Technologies
13.6.1 Agilent Technologies Company Information
13.6.2 Agilent Technologies Lung Cancer Biomarkers Product Portfolios and Specifications
13.6.3 Agilent Technologies Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Agilent Technologies Main Business Overview
13.6.5 Agilent Technologies Latest Developments
13.7 Biomerieux SA
13.7.1 Biomerieux SA Company Information
13.7.2 Biomerieux SA Lung Cancer Biomarkers Product Portfolios and Specifications
13.7.3 Biomerieux SA Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Biomerieux SA Main Business Overview
13.7.5 Biomerieux SA Latest Developments
13.8 Merck
13.8.1 Merck Company Information
13.8.2 Merck Lung Cancer Biomarkers Product Portfolios and Specifications
13.8.3 Merck Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merck Main Business Overview
13.8.5 Merck Latest Developments
13.9 Abbott Laboratories
13.9.1 Abbott Laboratories Company Information
13.9.2 Abbott Laboratories Lung Cancer Biomarkers Product Portfolios and Specifications
13.9.3 Abbott Laboratories Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Abbott Laboratories Main Business Overview
13.9.5 Abbott Laboratories Latest Developments
13.10 Becton, Dickinson and Company
13.10.1 Becton, Dickinson and Company Company Information
13.10.2 Becton, Dickinson and Company Lung Cancer Biomarkers Product Portfolios and Specifications
13.10.3 Becton, Dickinson and Company Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Becton, Dickinson and Company Main Business Overview
13.10.5 Becton, Dickinson and Company Latest Developments
13.11 Danaher Corporation
13.11.1 Danaher Corporation Company Information
13.11.2 Danaher Corporation Lung Cancer Biomarkers Product Portfolios and Specifications
13.11.3 Danaher Corporation Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Danaher Corporation Main Business Overview
13.11.5 Danaher Corporation Latest Developments
13.12 Myriad Genetics
13.12.1 Myriad Genetics Company Information
13.12.2 Myriad Genetics Lung Cancer Biomarkers Product Portfolios and Specifications
13.12.3 Myriad Genetics Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Myriad Genetics Main Business Overview
13.12.5 Myriad Genetics Latest Developments
13.13 Sysmex Corporation
13.13.1 Sysmex Corporation Company Information
13.13.2 Sysmex Corporation Lung Cancer Biomarkers Product Portfolios and Specifications
13.13.3 Sysmex Corporation Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sysmex Corporation Main Business Overview
13.13.5 Sysmex Corporation Latest Developments
13.14 Hologic
13.14.1 Hologic Company Information
13.14.2 Hologic Lung Cancer Biomarkers Product Portfolios and Specifications
13.14.3 Hologic Lung Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Hologic Main Business Overview
13.14.5 Hologic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lung Cancer Biomarkers Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Lung Cancer Biomarkers Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Protein Biomarker
Table 4. Major Players of Genetic Biomarker
Table 5. Global Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 6. Global Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Table 7. Global Lung Cancer Biomarkers Revenue by Type (2020-2025) & ($ million)
Table 8. Global Lung Cancer Biomarkers Revenue Market Share by Type (2020-2025)
Table 9. Global Lung Cancer Biomarkers Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Lung Cancer Biomarkers Sale by Application (2020-2025) & (Units)
Table 11. Global Lung Cancer Biomarkers Sale Market Share by Application (2020-2025)
Table 12. Global Lung Cancer Biomarkers Revenue by Application (2020-2025) & ($ million)
Table 13. Global Lung Cancer Biomarkers Revenue Market Share by Application (2020-2025)
Table 14. Global Lung Cancer Biomarkers Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Lung Cancer Biomarkers Sales by Company (2020-2025) & (Units)
Table 16. Global Lung Cancer Biomarkers Sales Market Share by Company (2020-2025)
Table 17. Global Lung Cancer Biomarkers Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Lung Cancer Biomarkers Revenue Market Share by Company (2020-2025)
Table 19. Global Lung Cancer Biomarkers Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Lung Cancer Biomarkers Producing Area Distribution and Sales Area
Table 21. Players Lung Cancer Biomarkers Products Offered
Table 22. Lung Cancer Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Lung Cancer Biomarkers Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global Lung Cancer Biomarkers Sales Market Share Geographic Region (2020-2025)
Table 27. Global Lung Cancer Biomarkers Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Lung Cancer Biomarkers Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Lung Cancer Biomarkers Sales by Country/Region (2020-2025) & (Units)
Table 30. Global Lung Cancer Biomarkers Sales Market Share by Country/Region (2020-2025)
Table 31. Global Lung Cancer Biomarkers Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Lung Cancer Biomarkers Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Lung Cancer Biomarkers Sales by Country (2020-2025) & (Units)
Table 34. Americas Lung Cancer Biomarkers Sales Market Share by Country (2020-2025)
Table 35. Americas Lung Cancer Biomarkers Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 37. Americas Lung Cancer Biomarkers Sales by Application (2020-2025) & (Units)
Table 38. APAC Lung Cancer Biomarkers Sales by Region (2020-2025) & (Units)
Table 39. APAC Lung Cancer Biomarkers Sales Market Share by Region (2020-2025)
Table 40. APAC Lung Cancer Biomarkers Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 42. APAC Lung Cancer Biomarkers Sales by Application (2020-2025) & (Units)
Table 43. Europe Lung Cancer Biomarkers Sales by Country (2020-2025) & (Units)
Table 44. Europe Lung Cancer Biomarkers Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 46. Europe Lung Cancer Biomarkers Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa Lung Cancer Biomarkers Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa Lung Cancer Biomarkers Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 50. Middle East & Africa Lung Cancer Biomarkers Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Lung Cancer Biomarkers
Table 52. Key Market Challenges & Risks of Lung Cancer Biomarkers
Table 53. Key Industry Trends of Lung Cancer Biomarkers
Table 54. Lung Cancer Biomarkers Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Lung Cancer Biomarkers Distributors List
Table 57. Lung Cancer Biomarkers Customer List
Table 58. Global Lung Cancer Biomarkers Sales Forecast by Region (2026-2031) & (Units)
Table 59. Global Lung Cancer Biomarkers Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Lung Cancer Biomarkers Sales Forecast by Country (2026-2031) & (Units)
Table 61. Americas Lung Cancer Biomarkers Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Lung Cancer Biomarkers Sales Forecast by Region (2026-2031) & (Units)
Table 63. APAC Lung Cancer Biomarkers Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Lung Cancer Biomarkers Sales Forecast by Country (2026-2031) & (Units)
Table 65. Europe Lung Cancer Biomarkers Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Lung Cancer Biomarkers Sales Forecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa Lung Cancer Biomarkers Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Lung Cancer Biomarkers Sales Forecast by Type (2026-2031) & (Units)
Table 69. Global Lung Cancer Biomarkers Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Lung Cancer Biomarkers Sales Forecast by Application (2026-2031) & (Units)
Table 71. Global Lung Cancer Biomarkers Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Bio-Rad Laboratories Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 73. Bio-Rad Laboratories Lung Cancer Biomarkers Product Portfolios and Specifications
Table 74. Bio-Rad Laboratories Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Bio-Rad Laboratories Main Business
Table 76. Bio-Rad Laboratories Latest Developments
Table 77. Roche Diagnostics Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 78. Roche Diagnostics Lung Cancer Biomarkers Product Portfolios and Specifications
Table 79. Roche Diagnostics Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Roche Diagnostics Main Business
Table 81. Roche Diagnostics Latest Developments
Table 82. Qiagen Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 83. Qiagen Lung Cancer Biomarkers Product Portfolios and Specifications
Table 84. Qiagen Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Qiagen Main Business
Table 86. Qiagen Latest Developments
Table 87. Illumina Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 88. Illumina Lung Cancer Biomarkers Product Portfolios and Specifications
Table 89. Illumina Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Illumina Main Business
Table 91. Illumina Latest Developments
Table 92. GE Healthcare Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 93. GE Healthcare Lung Cancer Biomarkers Product Portfolios and Specifications
Table 94. GE Healthcare Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. GE Healthcare Main Business
Table 96. GE Healthcare Latest Developments
Table 97. Agilent Technologies Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 98. Agilent Technologies Lung Cancer Biomarkers Product Portfolios and Specifications
Table 99. Agilent Technologies Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Agilent Technologies Main Business
Table 101. Agilent Technologies Latest Developments
Table 102. Biomerieux SA Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 103. Biomerieux SA Lung Cancer Biomarkers Product Portfolios and Specifications
Table 104. Biomerieux SA Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Biomerieux SA Main Business
Table 106. Biomerieux SA Latest Developments
Table 107. Merck Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck Lung Cancer Biomarkers Product Portfolios and Specifications
Table 109. Merck Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Merck Main Business
Table 111. Merck Latest Developments
Table 112. Abbott Laboratories Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 113. Abbott Laboratories Lung Cancer Biomarkers Product Portfolios and Specifications
Table 114. Abbott Laboratories Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Abbott Laboratories Main Business
Table 116. Abbott Laboratories Latest Developments
Table 117. Becton, Dickinson and Company Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 118. Becton, Dickinson and Company Lung Cancer Biomarkers Product Portfolios and Specifications
Table 119. Becton, Dickinson and Company Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Becton, Dickinson and Company Main Business
Table 121. Becton, Dickinson and Company Latest Developments
Table 122. Danaher Corporation Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 123. Danaher Corporation Lung Cancer Biomarkers Product Portfolios and Specifications
Table 124. Danaher Corporation Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Danaher Corporation Main Business
Table 126. Danaher Corporation Latest Developments
Table 127. Myriad Genetics Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 128. Myriad Genetics Lung Cancer Biomarkers Product Portfolios and Specifications
Table 129. Myriad Genetics Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Myriad Genetics Main Business
Table 131. Myriad Genetics Latest Developments
Table 132. Sysmex Corporation Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 133. Sysmex Corporation Lung Cancer Biomarkers Product Portfolios and Specifications
Table 134. Sysmex Corporation Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Sysmex Corporation Main Business
Table 136. Sysmex Corporation Latest Developments
Table 137. Hologic Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 138. Hologic Lung Cancer Biomarkers Product Portfolios and Specifications
Table 139. Hologic Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Hologic Main Business
Table 141. Hologic Latest Developments
Table 1. Lung Cancer Biomarkers Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Lung Cancer Biomarkers Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Protein Biomarker
Table 4. Major Players of Genetic Biomarker
Table 5. Global Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 6. Global Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Table 7. Global Lung Cancer Biomarkers Revenue by Type (2020-2025) & ($ million)
Table 8. Global Lung Cancer Biomarkers Revenue Market Share by Type (2020-2025)
Table 9. Global Lung Cancer Biomarkers Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Lung Cancer Biomarkers Sale by Application (2020-2025) & (Units)
Table 11. Global Lung Cancer Biomarkers Sale Market Share by Application (2020-2025)
Table 12. Global Lung Cancer Biomarkers Revenue by Application (2020-2025) & ($ million)
Table 13. Global Lung Cancer Biomarkers Revenue Market Share by Application (2020-2025)
Table 14. Global Lung Cancer Biomarkers Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Lung Cancer Biomarkers Sales by Company (2020-2025) & (Units)
Table 16. Global Lung Cancer Biomarkers Sales Market Share by Company (2020-2025)
Table 17. Global Lung Cancer Biomarkers Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Lung Cancer Biomarkers Revenue Market Share by Company (2020-2025)
Table 19. Global Lung Cancer Biomarkers Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Lung Cancer Biomarkers Producing Area Distribution and Sales Area
Table 21. Players Lung Cancer Biomarkers Products Offered
Table 22. Lung Cancer Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Lung Cancer Biomarkers Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global Lung Cancer Biomarkers Sales Market Share Geographic Region (2020-2025)
Table 27. Global Lung Cancer Biomarkers Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Lung Cancer Biomarkers Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Lung Cancer Biomarkers Sales by Country/Region (2020-2025) & (Units)
Table 30. Global Lung Cancer Biomarkers Sales Market Share by Country/Region (2020-2025)
Table 31. Global Lung Cancer Biomarkers Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Lung Cancer Biomarkers Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Lung Cancer Biomarkers Sales by Country (2020-2025) & (Units)
Table 34. Americas Lung Cancer Biomarkers Sales Market Share by Country (2020-2025)
Table 35. Americas Lung Cancer Biomarkers Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 37. Americas Lung Cancer Biomarkers Sales by Application (2020-2025) & (Units)
Table 38. APAC Lung Cancer Biomarkers Sales by Region (2020-2025) & (Units)
Table 39. APAC Lung Cancer Biomarkers Sales Market Share by Region (2020-2025)
Table 40. APAC Lung Cancer Biomarkers Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 42. APAC Lung Cancer Biomarkers Sales by Application (2020-2025) & (Units)
Table 43. Europe Lung Cancer Biomarkers Sales by Country (2020-2025) & (Units)
Table 44. Europe Lung Cancer Biomarkers Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 46. Europe Lung Cancer Biomarkers Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa Lung Cancer Biomarkers Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa Lung Cancer Biomarkers Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Lung Cancer Biomarkers Sales by Type (2020-2025) & (Units)
Table 50. Middle East & Africa Lung Cancer Biomarkers Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Lung Cancer Biomarkers
Table 52. Key Market Challenges & Risks of Lung Cancer Biomarkers
Table 53. Key Industry Trends of Lung Cancer Biomarkers
Table 54. Lung Cancer Biomarkers Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Lung Cancer Biomarkers Distributors List
Table 57. Lung Cancer Biomarkers Customer List
Table 58. Global Lung Cancer Biomarkers Sales Forecast by Region (2026-2031) & (Units)
Table 59. Global Lung Cancer Biomarkers Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Lung Cancer Biomarkers Sales Forecast by Country (2026-2031) & (Units)
Table 61. Americas Lung Cancer Biomarkers Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Lung Cancer Biomarkers Sales Forecast by Region (2026-2031) & (Units)
Table 63. APAC Lung Cancer Biomarkers Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Lung Cancer Biomarkers Sales Forecast by Country (2026-2031) & (Units)
Table 65. Europe Lung Cancer Biomarkers Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Lung Cancer Biomarkers Sales Forecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa Lung Cancer Biomarkers Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Lung Cancer Biomarkers Sales Forecast by Type (2026-2031) & (Units)
Table 69. Global Lung Cancer Biomarkers Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Lung Cancer Biomarkers Sales Forecast by Application (2026-2031) & (Units)
Table 71. Global Lung Cancer Biomarkers Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Bio-Rad Laboratories Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 73. Bio-Rad Laboratories Lung Cancer Biomarkers Product Portfolios and Specifications
Table 74. Bio-Rad Laboratories Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Bio-Rad Laboratories Main Business
Table 76. Bio-Rad Laboratories Latest Developments
Table 77. Roche Diagnostics Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 78. Roche Diagnostics Lung Cancer Biomarkers Product Portfolios and Specifications
Table 79. Roche Diagnostics Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Roche Diagnostics Main Business
Table 81. Roche Diagnostics Latest Developments
Table 82. Qiagen Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 83. Qiagen Lung Cancer Biomarkers Product Portfolios and Specifications
Table 84. Qiagen Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Qiagen Main Business
Table 86. Qiagen Latest Developments
Table 87. Illumina Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 88. Illumina Lung Cancer Biomarkers Product Portfolios and Specifications
Table 89. Illumina Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Illumina Main Business
Table 91. Illumina Latest Developments
Table 92. GE Healthcare Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 93. GE Healthcare Lung Cancer Biomarkers Product Portfolios and Specifications
Table 94. GE Healthcare Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. GE Healthcare Main Business
Table 96. GE Healthcare Latest Developments
Table 97. Agilent Technologies Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 98. Agilent Technologies Lung Cancer Biomarkers Product Portfolios and Specifications
Table 99. Agilent Technologies Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Agilent Technologies Main Business
Table 101. Agilent Technologies Latest Developments
Table 102. Biomerieux SA Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 103. Biomerieux SA Lung Cancer Biomarkers Product Portfolios and Specifications
Table 104. Biomerieux SA Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Biomerieux SA Main Business
Table 106. Biomerieux SA Latest Developments
Table 107. Merck Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck Lung Cancer Biomarkers Product Portfolios and Specifications
Table 109. Merck Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Merck Main Business
Table 111. Merck Latest Developments
Table 112. Abbott Laboratories Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 113. Abbott Laboratories Lung Cancer Biomarkers Product Portfolios and Specifications
Table 114. Abbott Laboratories Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Abbott Laboratories Main Business
Table 116. Abbott Laboratories Latest Developments
Table 117. Becton, Dickinson and Company Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 118. Becton, Dickinson and Company Lung Cancer Biomarkers Product Portfolios and Specifications
Table 119. Becton, Dickinson and Company Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Becton, Dickinson and Company Main Business
Table 121. Becton, Dickinson and Company Latest Developments
Table 122. Danaher Corporation Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 123. Danaher Corporation Lung Cancer Biomarkers Product Portfolios and Specifications
Table 124. Danaher Corporation Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Danaher Corporation Main Business
Table 126. Danaher Corporation Latest Developments
Table 127. Myriad Genetics Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 128. Myriad Genetics Lung Cancer Biomarkers Product Portfolios and Specifications
Table 129. Myriad Genetics Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Myriad Genetics Main Business
Table 131. Myriad Genetics Latest Developments
Table 132. Sysmex Corporation Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 133. Sysmex Corporation Lung Cancer Biomarkers Product Portfolios and Specifications
Table 134. Sysmex Corporation Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Sysmex Corporation Main Business
Table 136. Sysmex Corporation Latest Developments
Table 137. Hologic Basic Information, Lung Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 138. Hologic Lung Cancer Biomarkers Product Portfolios and Specifications
Table 139. Hologic Lung Cancer Biomarkers Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Hologic Main Business
Table 141. Hologic Latest Developments
LIST OF FIGURES
Figure 1. Picture of Lung Cancer Biomarkers
Figure 2. Lung Cancer Biomarkers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lung Cancer Biomarkers Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Lung Cancer Biomarkers Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Lung Cancer Biomarkers Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Lung Cancer Biomarkers Sales Market Share by Country/Region (2024)
Figure 10. Lung Cancer Biomarkers Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Protein Biomarker
Figure 12. Product Picture of Genetic Biomarker
Figure 13. Global Lung Cancer Biomarkers Sales Market Share by Type in 2025
Figure 14. Global Lung Cancer Biomarkers Revenue Market Share by Type (2020-2025)
Figure 15. Lung Cancer Biomarkers Consumed in Diagnostics
Figure 16. Global Lung Cancer Biomarkers Market: Diagnostics (2020-2025) & (Units)
Figure 17. Lung Cancer Biomarkers Consumed in Research
Figure 18. Global Lung Cancer Biomarkers Market: Research (2020-2025) & (Units)
Figure 19. Lung Cancer Biomarkers Consumed in Others
Figure 20. Global Lung Cancer Biomarkers Market: Others (2020-2025) & (Units)
Figure 21. Global Lung Cancer Biomarkers Sale Market Share by Application (2024)
Figure 22. Global Lung Cancer Biomarkers Revenue Market Share by Application in 2025
Figure 23. Lung Cancer Biomarkers Sales by Company in 2025 (Units)
Figure 24. Global Lung Cancer Biomarkers Sales Market Share by Company in 2025
Figure 25. Lung Cancer Biomarkers Revenue by Company in 2025 ($ millions)
Figure 26. Global Lung Cancer Biomarkers Revenue Market Share by Company in 2025
Figure 27. Global Lung Cancer Biomarkers Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Lung Cancer Biomarkers Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Lung Cancer Biomarkers Sales 2020-2025 (Units)
Figure 30. Americas Lung Cancer Biomarkers Revenue 2020-2025 ($ millions)
Figure 31. APAC Lung Cancer Biomarkers Sales 2020-2025 (Units)
Figure 32. APAC Lung Cancer Biomarkers Revenue 2020-2025 ($ millions)
Figure 33. Europe Lung Cancer Biomarkers Sales 2020-2025 (Units)
Figure 34. Europe Lung Cancer Biomarkers Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Lung Cancer Biomarkers Sales 2020-2025 (Units)
Figure 36. Middle East & Africa Lung Cancer Biomarkers Revenue 2020-2025 ($ millions)
Figure 37. Americas Lung Cancer Biomarkers Sales Market Share by Country in 2025
Figure 38. Americas Lung Cancer Biomarkers Revenue Market Share by Country (2020-2025)
Figure 39. Americas Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Figure 40. Americas Lung Cancer Biomarkers Sales Market Share by Application (2020-2025)
Figure 41. United States Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Lung Cancer Biomarkers Sales Market Share by Region in 2025
Figure 46. APAC Lung Cancer Biomarkers Revenue Market Share by Region (2020-2025)
Figure 47. APAC Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Figure 48. APAC Lung Cancer Biomarkers Sales Market Share by Application (2020-2025)
Figure 49. China Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 53. India Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Lung Cancer Biomarkers Sales Market Share by Country in 2025
Figure 57. Europe Lung Cancer Biomarkers Revenue Market Share by Country (2020-2025)
Figure 58. Europe Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Figure 59. Europe Lung Cancer Biomarkers Sales Market Share by Application (2020-2025)
Figure 60. Germany Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 61. France Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Lung Cancer Biomarkers Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Lung Cancer Biomarkers Sales Market Share by Application (2020-2025)
Figure 68. Egypt Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Lung Cancer Biomarkers in 2025
Figure 74. Manufacturing Process Analysis of Lung Cancer Biomarkers
Figure 75. Industry Chain Structure of Lung Cancer Biomarkers
Figure 76. Channels of Distribution
Figure 77. Global Lung Cancer Biomarkers Sales Market Forecast by Region (2026-2031)
Figure 78. Global Lung Cancer Biomarkers Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Lung Cancer Biomarkers Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Lung Cancer Biomarkers Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Lung Cancer Biomarkers Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Lung Cancer Biomarkers Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Lung Cancer Biomarkers
Figure 2. Lung Cancer Biomarkers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lung Cancer Biomarkers Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Lung Cancer Biomarkers Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Lung Cancer Biomarkers Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Lung Cancer Biomarkers Sales Market Share by Country/Region (2024)
Figure 10. Lung Cancer Biomarkers Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Protein Biomarker
Figure 12. Product Picture of Genetic Biomarker
Figure 13. Global Lung Cancer Biomarkers Sales Market Share by Type in 2025
Figure 14. Global Lung Cancer Biomarkers Revenue Market Share by Type (2020-2025)
Figure 15. Lung Cancer Biomarkers Consumed in Diagnostics
Figure 16. Global Lung Cancer Biomarkers Market: Diagnostics (2020-2025) & (Units)
Figure 17. Lung Cancer Biomarkers Consumed in Research
Figure 18. Global Lung Cancer Biomarkers Market: Research (2020-2025) & (Units)
Figure 19. Lung Cancer Biomarkers Consumed in Others
Figure 20. Global Lung Cancer Biomarkers Market: Others (2020-2025) & (Units)
Figure 21. Global Lung Cancer Biomarkers Sale Market Share by Application (2024)
Figure 22. Global Lung Cancer Biomarkers Revenue Market Share by Application in 2025
Figure 23. Lung Cancer Biomarkers Sales by Company in 2025 (Units)
Figure 24. Global Lung Cancer Biomarkers Sales Market Share by Company in 2025
Figure 25. Lung Cancer Biomarkers Revenue by Company in 2025 ($ millions)
Figure 26. Global Lung Cancer Biomarkers Revenue Market Share by Company in 2025
Figure 27. Global Lung Cancer Biomarkers Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Lung Cancer Biomarkers Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Lung Cancer Biomarkers Sales 2020-2025 (Units)
Figure 30. Americas Lung Cancer Biomarkers Revenue 2020-2025 ($ millions)
Figure 31. APAC Lung Cancer Biomarkers Sales 2020-2025 (Units)
Figure 32. APAC Lung Cancer Biomarkers Revenue 2020-2025 ($ millions)
Figure 33. Europe Lung Cancer Biomarkers Sales 2020-2025 (Units)
Figure 34. Europe Lung Cancer Biomarkers Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Lung Cancer Biomarkers Sales 2020-2025 (Units)
Figure 36. Middle East & Africa Lung Cancer Biomarkers Revenue 2020-2025 ($ millions)
Figure 37. Americas Lung Cancer Biomarkers Sales Market Share by Country in 2025
Figure 38. Americas Lung Cancer Biomarkers Revenue Market Share by Country (2020-2025)
Figure 39. Americas Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Figure 40. Americas Lung Cancer Biomarkers Sales Market Share by Application (2020-2025)
Figure 41. United States Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Lung Cancer Biomarkers Sales Market Share by Region in 2025
Figure 46. APAC Lung Cancer Biomarkers Revenue Market Share by Region (2020-2025)
Figure 47. APAC Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Figure 48. APAC Lung Cancer Biomarkers Sales Market Share by Application (2020-2025)
Figure 49. China Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 53. India Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Lung Cancer Biomarkers Sales Market Share by Country in 2025
Figure 57. Europe Lung Cancer Biomarkers Revenue Market Share by Country (2020-2025)
Figure 58. Europe Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Figure 59. Europe Lung Cancer Biomarkers Sales Market Share by Application (2020-2025)
Figure 60. Germany Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 61. France Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Lung Cancer Biomarkers Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Lung Cancer Biomarkers Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Lung Cancer Biomarkers Sales Market Share by Application (2020-2025)
Figure 68. Egypt Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Lung Cancer Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Lung Cancer Biomarkers in 2025
Figure 74. Manufacturing Process Analysis of Lung Cancer Biomarkers
Figure 75. Industry Chain Structure of Lung Cancer Biomarkers
Figure 76. Channels of Distribution
Figure 77. Global Lung Cancer Biomarkers Sales Market Forecast by Region (2026-2031)
Figure 78. Global Lung Cancer Biomarkers Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Lung Cancer Biomarkers Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Lung Cancer Biomarkers Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Lung Cancer Biomarkers Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Lung Cancer Biomarkers Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Blood Purification Machine Market Growth 2023-2029
US$ 3,660.00
March 2023
101 pages
Global Swollen Knee Treatment Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
113 pages
Global Cancellous Sponges Market Growth 2025-2031
US$ 3,660.00
April 2025
91 pages
Global 3D Printing for Medical Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
152 pages
Global Automatic Opening Laparoscopic Retrieval Bag Market Growth 2024-2030
US$ 3,660.00
March 2024
116 pages
